The top four TFs identified at 67% of the CLL‐specific alternative promoters were the lineage‐associated TFs FOXA1, LEF1, POU3F1, and REPIN1 (Appendix Fig S3B). This evidence concerns the gene LEF1 and B-cell chronic lymphocytic leukemia.